Lipoproteins containing apolipoprotein B isolated from patients with abetalipoproteinemia and homozygous hypobetalipoproteinemia: identification and characterization. 1995

G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
Serlia, Inserm U325, Institut Pasteur, Lille, France.

Abetalipoproteinemia (ABL) and homozygous hypobetalipoproteinemia (HBL) are inherited disorders which are classically characterized by progressive retinal and spinocerebellar disease, fat-soluble vitamin deficiency, and absence of apolipoprotein (apo) B from the plasma. Using immunoaffinity chromatography with an anti-apo B antiserum, we isolated apo B-containing lipoprotein (LpB) particles from the plasma of 4 ABL and 2 HBL patients. The LpB particles were characterized and compared with low density lipoprotein (LDL) and LpB isolated from normal plasma. The ABL/HBL LpB particles were similar in size and charge to normal LpB particles but were relatively enriched in several other apolipoproteins. They contained alpha-tocopherol in a ratio to cholesterol that was proportionately much higher than the very low ratio of alpha-tocopherol to cholesterol in plasma. They bound saturably to fibroblasts and were internalized and degraded similarly to LDL. Hence, the molecular defects in ABL and HBL permit the secretion of a very small number of apo B-containing lipoproteins which may be important for transport of alpha-tocopherol to peripheral tissues.

UI MeSH Term Description Entries
D006995 Hypobetalipoproteinemias Conditions with abnormally low levels of BETA-LIPOPROTEINS (low density lipoproteins or LDL) in the blood. It is defined as LDL values equal to or less than the 5th percentile for the population. They include the autosomal dominant form involving mutation of the APOLIPOPROTEINS B gene, and the autosomal recessive form involving mutation of the microsomal triglyceride transfer protein. All are characterized by low LDL and dietary fat malabsorption. Familial Hypobetalipoproteinemia,Hypo beta Lipoproteinemia,Hypobetalipoproteinemia,Hypo beta Lipoproteinemias
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes

Related Publications

G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
March 2009, Clinica chimica acta; international journal of clinical chemistry,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
March 1989, Atherosclerosis,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
December 1982, The Journal of clinical investigation,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
January 1986, Methods in enzymology,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
January 1996, Methods in enzymology,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
May 2014, Journal of inherited metabolic disease,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
May 1994, Human molecular genetics,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
June 2014, Current opinion in lipidology,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
November 1979, Metabolism: clinical and experimental,
G A Aguie, and D J Rader, and V Clavey, and M G Traber, and G Torpier, and H J Kayden, and J C Fruchart, and H B Brewer, and G Castro
March 1991, The Journal of biological chemistry,
Copied contents to your clipboard!